Federal award (PURCHASE ORDER, fiscal year 2021)
Recipient: TRAVERE THERAPEUTICS, INC.
Awarding agency: Department of Veterans Affairs / Department of Veterans Affairs
Funding agency: Department of Veterans Affairs / Department of Veterans Affairs
Period of performance: 2022-04-01 to 2022-09-30
Current total value of award: $236500
Description: CHENODAL 250MG